Arcus Biosciences

Filed a patent for "tetralins targeting g323e mutant hif-2a" on Wed, August 16, 2023

Filed a patent for "cbl-b inhibitors and methods of use thereof" on Thu, December 26, 2024

Filed a patent for "cbl-b inhibitors and methods of use thereof" on Fri, May 5, 2023

Filed a patent for "cbl-b inhibitors and methods of use thereof" on Thu, May 25, 2023

Filed a patent for "biomarkers for predicting cancer treatment efficacy" on Fri, June 2, 2023

Filed a patent for "biomarkers for predicting cancer treatment efficacy" on Tue, September 19, 2023

Filed a patent for "cbl-b inhibitors and methods of use thereof" on Fri, January 19, 2024

Filed a patent for "cbl-b inhibitors and methods of use thereof" on Fri, January 19, 2024

Filed a patent for "biomarkers for predicting cancer treatment efficacy" on Mon, May 20, 2024

Filed a patent for "tetralin and tetrahydroquinoline compounds as inhibitors of hif-2alpha" on Thu, August 1, 2024

Filed a patent for "combination therapy for treating tumor antigen expressing cancers" on Thu, July 7, 2022

Filed a patent for "combination therapy for treating trop-2 expressing cancers" on Tue, August 2, 2022

Filed a patent for "dosing with an azolopyrimidine compound" on Fri, September 2, 2022

Filed a patent for "dispersions of etrumadenant" on Wed, September 14, 2022

Filed a patent for "combination therapy for treating tumor antigen expressing cancers" on Fri, September 30, 2022

Filed a patent for "combination therapy for treating trop-2 expressing cancers" on Fri, September 30, 2022

Filed a patent for "hpk1 inhibitors and methods of use thereof" on Fri, October 14, 2022

Filed a patent for "lyophilized formulations of cd73 compounds" on Thu, October 20, 2022

Filed a patent for "processes for preparing azolopyrimidine compounds" on Wed, November 2, 2022

Filed a patent for "anti-tigit antibodies and uses of the same" on Wed, November 23, 2022

Filed a patent for "dispersions of etrumadenant" on Thu, December 15, 2022

Filed a patent for "anti-tigit antibodies and uses of the same" on Fri, December 16, 2022

Filed a patent for "inhibitors of hpk1 and methods of use thereof" on Fri, February 17, 2023

Filed a patent for "anti-cd39 antibodies and use thereof" on Thu, February 1, 2024

Filed a patent for "cbl-b inhibitors and methods of use thereof" on Fri, April 7, 2023